SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-24-036204
Filing Date
2024-08-07
Accepted
2024-08-07 16:14:52
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 ny20029500x5_424b3.htm 424B3 3184139
2 logo_acasti.jpg GRAPHIC 21485
3 ny20029500x5_annexb-img01.jpg GRAPHIC 772729
4 ny20029500x5_annexb-img02.jpg GRAPHIC 293804
5 ny20029500x5_annexb-img03.jpg GRAPHIC 428789
6 ny20029500x5_annexb-img04.jpg GRAPHIC 380675
7 ny20029500x5_annexb-img05.jpg GRAPHIC 639876
8 ny20029500x5_chart01.jpg GRAPHIC 149420
9 ny20029500x5_chart02.jpg GRAPHIC 139951
  Complete submission text file 0001140361-24-036204.txt   7076030
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 424B3 | Act: 33 | File No.: 333-280536 | Film No.: 241183942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)